Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Arbolí, Eduardo https://orcid.org/0000-0002-2237-6733
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Eder, Matthias
Brecht, Arne
Blau, Igor Wolfgang
Huynh, Anne
Forcade, Edouard https://orcid.org/0000-0002-8873-2868
Tischer, Johanna
Bethge, Wolfgang https://orcid.org/0000-0001-6052-2618
Bondarenko, Sergey
Verbeek, Mareike
Bulabois, Claude Eric
Einsele, Hermann https://orcid.org/0000-0002-7680-0819
Stölzel, Friedrich https://orcid.org/0000-0003-0653-5332
Savani, Bipin
Spyridonidis, Alexandros https://orcid.org/0000-0003-3097-2532
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Giebel, Sebastian
Brissot, Eolia
Schmid, Christoph https://orcid.org/0000-0001-7070-487X
Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CM19/00194)
- License Information
-
More Information
Article History
Received: 15 July 2021
Revised: 16 December 2021
Accepted: 4 February 2022
First Online: 7 April 2022
Competing interests
: ERA and CS have received speaker fees from Eurocept Pharmaceuticals. The remaining authors declare no competing financial interests.
